Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension
暂无分享,去创建一个
R. Benza | V. Tapson | L. Rubin | A. Nelsen | E. Rosenzweig | R. Bourge | R. Channick | S. Shapiro | Z. Safdar | R. J. White | C. McSwain | S. Gotzkowsky | R. White | S. K. Gotzkowsky
[1] S. Zyoud,et al. Self-reported medication adherence and treatment satisfaction in patients with epilepsy , 2011, Epilepsy & Behavior.
[2] E. Tay,et al. Quality of life and functional capacity can be improved in patients with Eisenmenger syndrome with oral sildenafil therapy. , 2011, International journal of cardiology.
[3] Horst Olschewski,et al. Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial. , 2010, Journal of the American College of Cardiology.
[4] Jyh‐Horng Wang,et al. Etoricoxib improves pain, function and quality of life: results of a real‐world effectiveness trial , 2010, International journal of rheumatic diseases.
[5] P. Mavros,et al. Patient‐reported outcomes in a survey of patients treated with oral antihyperglycaemic medications: associations with hypoglycaemia and weight gain , 2009, Diabetes, obesity & metabolism.
[6] S. McKenna,et al. The responsiveness and validity of the CAMPHOR Utility Index , 2008, European Respiratory Journal.
[7] H. Palevsky,et al. Evaluation of disease-specific health-related quality of life in patients with pulmonary arterial hypertension. , 2008, Respiratory medicine.
[8] R. Benza,et al. Dose Proportionality of Treprostinil Sodium Administered by Continuous Subcutaneous and Intravenous Infusion , 2008, Journal of clinical pharmacology.
[9] C. Ricachinevsky,et al. Treatment of pulmonary arterial hypertension. , 2006, Jornal de pediatria.
[10] W. Seeger,et al. Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in pulmonary arterial hypertension. , 2006, Journal of the American College of Cardiology.
[11] D. Meads,et al. The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): A Measure of Health-Related Quality of Life and Quality of Life for Patients with Pulmonary Hypertension , 2006, Quality of Life Research.
[12] H. Palevsky,et al. Health-related quality of life in patients with pulmonary arterial hypertension , 2005, Respiratory research.
[13] M. Gould,et al. Health-related quality of life in patients with pulmonary arterial hypertension. , 2004, Chest.
[14] T. Hunt,et al. Pharmacokinetics and Steady-State Bioequivalence of Treprostinil Sodium (Remodulin®) Administered by the Intravenous and Subcutaneous Route to Normal Volunteers , 2004, Journal of cardiovascular pharmacology.
[15] R. Barst,et al. Prostanoid therapy for pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.
[16] M. Humbert,et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.
[17] W. Seeger,et al. Prostacyclin and its analogues in the treatment of pulmonary hypertension. , 2004, Pharmacology & therapeutics.
[18] M. Atkinson,et al. Health and Quality of Life Outcomes , 2004 .
[19] W. Seeger,et al. Inhaled iloprost for severe pulmonary hypertension. , 2002, The New England journal of medicine.
[20] S. Rich,et al. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. , 2002, American journal of respiratory and critical care medicine.
[21] Inda,et al. A COMPARISON OF CONTINUOUS INTRAVENOUS EPOPROSTENOL ( PROSTACYCLIN ) WITH CONVENTIONAL THERAPY FOR PRIMARY PULMONARY HYPERTENSION , 2000 .
[22] W. Seeger,et al. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis. , 1999, American journal of respiratory and critical care medicine.
[23] W. Seeger,et al. Effects of inhaled versus intravenous vasodilators in experimental pulmonary hypertension. , 1997, The European respiratory journal.
[24] B. Groves,et al. Prostacyclin‐induced Acute Pulmonary Vasodilation in Primary Pulmonary Hypertension , 1982, Circulation.